Target intelligence / Profile preview

Pleckstrin homology domain-containing family N member 1 (PLEKHN1)

Target
PLEKHN1
Molecular classification
Other (PH domain-containing protein), Lipid-binding protein
01

Overview

Pleckstrin homology domain-containing family N member 1 (PLEKHN1) is a phospholipid-binding protein characterized by the presence of pleckstrin homology (PH) domains, which facilitate interactions with various lipid species, including cardiolipin, phosphatidic acid, phosphatidylinositol 4-phosphate, and phosphatidylserine. PLEKHN1 localizes to the mitochondrial membrane and cytoskeleton and plays a key role in apoptosis, where it promotes Bax-Bak hetero-oligomerization via interaction with Bid, a pro-apoptotic Bcl-2 family member. Loss of PLEKHN1 protects cancer cells from apoptosis and is linked to resistance against hypoxia-induced cell death, implicating PLEKHN1 in tumor biology and drug resistance. It also participates in RNA biology by regulating stability of specific mRNAs (e.g., leptin mRNA) through interactions with the RNA stabilizer ELAVL1. PLEKHN1 interacts with proteins involved in the inflammatory response and can be found in vesicular compartments, nucleus, and mitochondria, suggesting diverse cellular functions. There are currently no known drugs directly targeting PLEKHN1, and its mechanism-of-action as a therapeutic target remains to be established.

Other names
Pleckstrin homology domain containing N1PH domain-containing family N member 1Cardiolipin and phosphatidic acid-binding proteinCLPABPDKFZP434H2010
02

Biological functions

Phospholipid binding activityPositive regulation of apoptotic process (pro-apoptotic protein)3'-UTR-mediated mRNA destabilization (regulation of mRNA stability)Response to hypoxia
03

Disease associations

Cancer (notably colorectal and gastric cancers)Neuropathy, hereditary sensory and autonomic, types V and VIInflammation (implicated via protein interaction networks)
04

Biomarkers

Downregulation/absence may be a biomarker of drug resistance in cancer (especially at transition zones of normal and cancer tissue)

Beyond the preview

Go deeper on Pleckstrin homology domain-containing family N member 1 (PLEKHN1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pleckstrin homology domain-containing family N member 1 (PLEKHN1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call